| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc. | Director | Stock Option (right to buy) | 123,500 | 12 Jun 2025 | Direct | ||
| ESSA Pharma Inc. | Director | Options | 50,000 | 25 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 17:28 |
| CNTX | Context Therapeutics Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 07:50 |
| EPIX | ESSA Pharma Inc. | 25 Mar 2024 | 1 | $0 | 4 | Director | 28 Mar 2024, 12:34 |
| CNTX | Context Therapeutics Inc. | 31 May 2023 | 1 | $0 | 4 | Director | 31 May 2023, 16:53 |
| EPIX | ESSA Pharma Inc. | 13 Sep 2022 | 0 | $0 | 3 | Director | 21 Sep 2022, 19:39 |
| CNTX | Context Therapeutics Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:10 |
| CNTX | Context Therapeutics Inc. | 19 Oct 2021 | 0 | $0 | 3 | Director | 19 Oct 2021, 17:56 |